XR5944 Uses, Dosage, Side Effects and more
XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.
| Trade Name | XR5944 |
| Generic | XR5944 |
| Type | |
| Formula | C34H34N8O2 |
| Weight | Average: 586.7 Monoisotopic: 586.280472367 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in solid tumors.
How XR5944 works
XR5944 is a novel DNA targeting agent that in preclinical studies has demonstrated a high level of anti-tumor activity, both in vitro and in vivo, against a number of human tumor models. In human tumor xenograft models, treatment with XR5944 caused both partial and complete regression of large established tumors.
